Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CTRC | Q99895 | 1/20 | 0.32 |
| ▸ | GCGR | P47871 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL430510 | 0.83 | TYR (0.35) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL815042 | 0.81 | TYR (0.34) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL816883 | 0.81 | TYR (0.34) | TYRHTTNPC1HPGDMAPK1 | |
| SCHEMBL817129 | 0.81 | TYR (0.36) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL981990 | 0.80 | TYR (0.38) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL815293 | 0.80 | TYR (0.38) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL815591 | 0.79 | TYR (0.40) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL2967957 | 0.79 | TYR (0.40) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL2973976 | 0.79 | TYR (0.40) | TYRHTTMEN1TP53CYP3A4 | |
| SCHEMBL2972599 | 0.79 | TYR (0.40) | TYRHTTMEN1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1454931-B1 | PROPYLENE BLOCK COPOLYMER | JAPAN POLYPROPYLENE CORP (JP) | 2018-01-24 | — | — | EP | disclosed |
| EP-2009017-B1 | NOVEL TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING PROPYLENE/ETHYLENE-ALPHA -OLEFIN BLOCK COPOLYMER BY USING THE CATALYST | JAPAN POLYPROPYLENE CORP (JP) | 2013-06-26 | — | — | EP | disclosed |
| US-7906599-B2 | Transition metal compound, catalyst for olefin polymerization containing the same, and method for producing propylene/ethylene-α-olefin block copolymer by using the catalyst | JAPAN POLYPROPYLENE CORPORATION (JP) | 2011-03-15 | — | — | US | disclosed |
| US-20090099310-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING PROPYLENE/ETHYLENE-ALPHA-OLEFIN BLOCK COPOLYMER BY USING THE CATALYST | JAPAN POLYPROPYLENE CORPORATION (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-2009017-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING PROPYLENE/ETHYLENE-ALPHA -OLEFIN BLOCK COPOLYMER BY USING THE CATALYST | Japan Polypropylene Corporation (JP) | 2008-12-31 | — | — | EP | disclosed |
| US-6916886-B2 | Propylene block copolymer | JAPAN POLYPROPYLENE CORPORATION (JP) | 2005-07-12 | — | — | US | disclosed |
| US-20050009993-A1 | Propylene block copolymer | JAPAN POLYPROPYLENE CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1454931-A1 | PROPYLENE BLOCK COPOLYMER | Japan Polypropylene Corporation (JP) | 2004-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099310-A1 | NOVEL TRANSITION METAL COMPOUND, CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE SAME, AND METHOD FOR PRODUCING PROPYLENE/ETHYLENE-ALPHA-OLEFIN BLOCK COPOLYMER BY USING THE CATALYST | ALOX12, ETFB, POF1B | TYR 2003/4885HTT 4849/4885MEN1 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.